S3, E5: Special Analysis: What's going on with European Biotech? - Reporting from BioEurope in Vienna

In this special on-the-ground episode of Raising Biotech, Surani takes you inside BIO-Europe 2025 in Vienna — the dealmaking, the caffeine, and the cautious optimism shaping Europe’s biotech landscape right now.

Over three packed days, 6,000+ attendees from more than 60 countries gathered to broker partnerships, court investors, and debate what’s next for the industry. Surani attended panels, spoke with companies, investors and experts on the ground, and gives her observations and analysis.

This episode includes a special conversation with Patrik Frei, CEO and Founder of Venture Valuation AG — who shares insights on valuations, investor behaviour, and why Europe might quietly be regaining its strategic importance.

In this episode:

How US pricing policy shifts are reshaping European biotech strategy

China's growing dominance may require Europe to proactively collaborate

What investors are really rewarding right now: proof over promise

Why founders must raise with confidence and plan beyond the next milestone

Exploring investor psychology and the quiet reset in European biotech

Music featured in this episode: Wolfgang Amadeus Mozart — “Eine kleine Nachtmusik” (I. Allegro) and “Rondo alla Turca” (Turkish March).

Both recordings are in the public domain, courtesy of GregorQuendel